Quick Answer: Floraplex Terpenes (FLPX, LLC) is a Michigan-based botanical and CDT terpene supplier that has operated through BuyTerpenesOnline.com since 2018. The catalog covers botanical blends, CDT lines, flavor-boosted Amped formulations, and individual isolates, all positioned around competitive pricing. For B2B formulators, that affordability comes with real trade-offs: product pages carry almost no terpene composition data, COAs are produced in-house and measure only basic physical characteristics, and in 2019 the company was subpoenaed by New York State after its “Uber Thick” diluent product was found to contain nearly pure vitamin E acetate, a compound directly linked to EVALI hospitalizations. This review covers what the company is, what it sells, and what the documentation gaps mean for formulators who need traceable, verified inputs.
Key Takeaways
- Floraplex is a Michigan-based supplier offering botanical blends, CDT lines, Amped flavour formulations, and isolates through BuyTerpenesOnline.com.
- Its affordability and catalog range come with documentation gaps, including limited product-page composition data and in-house COAs focused on basic physical characteristics.
- Floraplex’s CDT lines include Pure, Fusion, and Amped options, but lack public cultivation origins, extraction methodology, and harvest handling details.
- In 2019, New York State subpoenaed Floraplex after its Uber Thick diluent was reportedly found to contain nearly pure vitamin E acetate.
- Formulators should treat missing terpene panels, third-party lab results, contaminant testing, and source traceability as material B2B sourcing risks.
- Terpene Belt Farms provides California-grown hemp, Fresh Never Frozen extraction, ISO/IEC 17025-accredited testing, full terpene panel data, and cGMP-certified processing.
- Ready to see what proper documented products should look like? Shop our samples to learn more today.
Searching for a terpene supplier is straightforward enough. Finding one that provides the documentation a formulator actually needs to make a confident sourcing decision is a different exercise entirely.
Most buyers start with price and catalog depth, and Floraplex checks both boxes: accessible pricing across a wide product range. What becomes harder to evaluate from the outside is what’s backing those products: the testing methodology, the source traceability, the COA standard, and the company’s own history.
A terpene supplier isn’t selling you a flavor profile in isolation. They’re providing an ingredient that goes into a finished product your customers will consume, which means the burden of proof on purity, composition, and safety belongs with the supplier.
For brands that take COA review seriously, there are specific questions worth asking about Floraplex that don’t get answered by browsing the product catalog. Quite a bit gets left off those pages, and the Floraplex story includes a chapter from 2019 that any due-diligence-minded buyer should read before placing an order.
An Overview of Floraplex Terpenes
Floraplex Terpenes is a terpene manufacturer and distributor operating primarily through BuyTerpenesOnline.com. The company offers botanical terpene blends, CDT lines, flavor-forward Amped Up formulations, and individual isolates, marketed primarily on the basis of affordability and product variety.
Floraplex positions itself as a low-cost alternative to premium terpene suppliers, arguing on its site that higher prices don’t necessarily reflect higher quality.
The company is registered as FLPX, LLC and has been operating since 2018. It sells to both retail consumers and B2B buyers, an unusual positioning in a space where most CDT suppliers focus exclusively on commercial accounts. That mixed audience means the platform is optimized for accessibility rather than technical depth, and the product documentation reflects that priority.
What Floraplex is not is a vertically integrated CDT producer. Its botanical blends are formulated from non-cannabis plant isolates, and its CDT lines are assembled from sourced hemp-derived material rather than extracted on-site from proprietary cultivars.
Floraplex Terpenes Background
Floraplex has been in the market since 2018, putting it at roughly eight years of operation as of 2026. Longevity in this space is worth noting, but it doesn’t substitute for documentation quality or sourcing transparency when procurement teams run a supplier qualification process.
How Floraplex Got Started
The company launched in August 2018 with a direct-to-market approach through BuyTerpenesOnline.com. According to its initial public launch post on a cannabis industry forum, the founding team cited three motivations: interest in cannabis, interest in terpene chemistry, and a belief that existing suppliers charged too much while delivering inconsistent quality.
The team described itself as including a flavorist, a chemist, and formulation specialists. Strain profiles in the botanical blend line were constructed by pulling published GC-MS data and reconstructing those compounds from botanical isolates, essential oils, and in some tiers, added flavoring agents.
The legal entity behind the brand is FLPX, LLC. Alec Riffle is associated as CEO, with the trademark registration listing him as the contact. The FLORAPLEX trademark was filed in October 2018 and granted registration in the United States, with the filing explicitly specifying that the listed products do not contain cannabis-derived ingredients.
The company has since introduced CDT lines, but the original brand identity was built entirely on botanical formulations.
What the Brand Says About Itself
The About Us page on BuyTerpenesOnline.com is sparse to the point of being uninformative. It describes Floraplex as being “created by a team of experts in essential oils, chemistry, and product formulation” with products that are “consistently produced and controlled according to quality standards.”
There’s no reference to specific certifications, no information about what lab standard COAs are produced under, and no detail about sourcing relationships or extraction processes. For a B2B supplier, that level of company transparency is well below what most procurement teams now expect during initial supplier review.
Floraplex Major Product Categories
Floraplex’s catalog breaks into several distinct tiers, each with a different sourcing logic and intended audience. Here’s what each category actually contains and what it means for formulators evaluating sourcing options.
Botanical Terpene Blends
The core Floraplex product line consists of strain-inspired blends constructed from botanical terpene isolates sourced from non-cannabis plants. These are the foundational Floraplex products like Blue Dream, OG Kush, and Cookies priced from around $19.99 in small quantities up to gallon pricing. The company states these blends contain “dozens of unique and rare terpenes”.
The practical problem is that this composition data is not displayed on the product pages themselves. It requires navigating to a separate documents section and searching by product name, and for several products, the documents listed on that page are placeholders that just lead to their /documents page instead of the specific sheet a customer wants.
CDT Lines
Floraplex’s CDT offerings come in three configurations, each with a different blend of sourcing:
- Pure CDTs: Marketed as 100% hemp-derived live resin terpenes with strain-named profiles including Durban Poison, Bubba Kush, Skywalker OG, and London Pound Cake
- Fusion CDTs: A combination of Pure CDT material and botanical terpenes, designed to extend the CDT base while preserving some cannabis-derived character
- Amped CDTs: CDT base with additional flavoring compounds layered on top for a bolder sensory output
The Pure CDT tier is where Floraplex tries to compete in the premium CDT segment, with pricing running from $25 to $4,200 depending on volume. The critical issue for formulators is that the CDT lines carry no disclosed extraction methodology, no information about hemp cultivars or cultivation origins, and no details about how the live resin material was handled from harvest to bottling. A product labeled “100% hemp-derived” with no agricultural or extraction documentation gives a buyer very little to verify.
For reference, a properly documented CDT like 2024 Fruit #6 from Terpene Belt Farms traces directly to its source genetics, Guava, Stardawg Guava, and Guava Gelato cultivars, with a verified terpene panel showing Limonene at 25.41%, Caryophyllene at 16.05%, and Linalool at 4.42%.
Amped Up and Super Amped Up
These are flavor-first formulations that combine terpene bases with added flavoring compounds. Product names like Cherry Churro, Blue Slushie, Grape Soda, and Coconut Cream signal a consumer-facing candy market orientation rather than a B2B formulation tool.
These products aren’t designed for formulators pursuing authentic cannabis terpene profiles; they’re designed for vape products where aggressive flavor is the primary objective.
Terpene Isolates
Floraplex offers a standard range of individual terpene isolates including Alpha Pinene, Beta Caryophyllene, Limonene, Myrcene, Linalool, Humulene, Terpinolene, Ocimene, and others.
These are commodity isolates available from many suppliers, and the competitive angle Floraplex offers here is straightforward price accessibility. For formulators sourcing single compounds for custom blending work, basic spec sheet documentation is typically sufficient, and Floraplex does provide more accessible documentation for isolates than for its blends.
Floraplex New York State Subpoenas and the Uber Thick Controversy
In September 2019, New York State launched a formal investigation into companies selling products suspected of contributing to a vaping lung illness outbreak later identified as EVALI (e-cigarette, or vaping, product use-associated lung injury).
Floraplex Terpenes was one of three companies nationwide that New York officials subpoenaed, specifically over a diluent product called Uber Thick, which state lab testing found to be nearly pure vitamin E acetate.
What Uber Thick Was
Uber Thick was a vape diluent marketed for use by people manufacturing their own vape cartridges. Diluents are used to adjust the viscosity of cannabis oil so it fills cartridges correctly, and the market for these products expanded rapidly alongside the illicit cart trade.
The problem with vitamin E acetate as an inhalation product is severe: while considered safe for topical use and ingestion, research published in the New England Journal of Medicine found the compound in the lung fluid of 48 of 51 EVALI patients tested across 16 states, establishing a direct link between the substance and respiratory injury.
The same study found vitamin E acetate was absent in the lung fluid of healthy control subjects who did not have EVALI.
What the Subpoena Revealed
According to reporting by the Boston Globe, New York Governor Andrew Cuomo described the investigation as addressing a “frightening public health phenomenon,” and the state subpoena targeted Floraplex’s Uber Thick product alongside similar products from two other companies after lab tests found samples to be nearly pure vitamin E acetate.
The FDA confirmed vitamin E acetate as strongly linked to the national EVALI outbreak, and the CDC ultimately documented over 2,800 hospitalizations and 68 deaths across the United States.
A representative for Floraplex acknowledged in a public forum that Uber Thick had been sold but characterized it as a small fraction of the company’s overall sales volume. That post was later deleted.
What This Means for Sourcing Decisions
The Uber Thick episode doesn’t indict every Floraplex product. It does raise meaningful questions about what controls a supplier has in place over what it brings to market, how products are tested before release, and what visibility the company has into end-use applications.
A supplier that sold a product found to be nearly pure vitamin E acetate without adequate third-party COA documentation on that product demonstrates a quality gap that extends beyond a single SKU.
That gap is a legitimate factor in any sourcing evaluation. The broader calculus of why the true cost of cheap terpenes extends beyond unit price is worth working through before making a final call on any budget-positioned supplier.
Our Take on Floraplex Terpenes as a B2B Supplier
For a technical buyer running due diligence, there are specific, verifiable issues with Floraplex’s current setup. These observations are grounded in what the website actually shows, not speculation about what might be true behind the scenes.
Product Pages Provide Almost No Technical Information
A typical Floraplex product page offers a product name, a short flavor descriptor, and a price. The Grape Watermelon page, for example, describes the product as “juicy watermelon layered with bold purple grape sweetness” with nothing further.
There’s no terpene percentage breakdown, no dominant compound identification, and no information about what’s in the bottle beyond the sensory description. For a formulator adding a terpene blend to a product at 2% or 5% inclusion, that absence of composition data is a genuine sourcing risk.
Contrast that with what a documented CDT oil provides: a verified terpene panel listing every measurable compound with its percentage. A profile like Sweet #164 shows its composition directly: Myrcene at 23%, Pinene at 17.69%, Limonene at 14.02%, Caryophyllene at 9.02%, and Ocimene at 6.13%. That’s data a formulator can use at every stage from R&D through production QC.
COA Quality Falls Below Current Industry Standards
When you navigate to the Floraplex documents section and locate a COA, what you find is a document that records appearance, odor, refractive index, and specific gravity. There is no terpene composition panel, no pesticide residue results, no heavy metal analysis, no residual solvent data, no cannabinoid profile, and no microbial testing.
Additionally, these COAs are produced in-house rather than by an accredited third-party laboratory. For any B2B formulator whose finished product will face regulatory scrutiny or state-mandated compliance testing, an in-house COA that only measures physical characteristics provides almost no meaningful safety or composition assurance.
To summarize, the COAs contain absolutely zero useful information for anyone that wants to add these products to their lineup at scale.
Document Navigation Creates Additional Friction
Documents are housed on a separate page from the product listings, with no direct link from the product page itself to that product’s specific documents. Users have to navigate to the documents section and search by product name.
Reddit’s Take on Floraplex
Community sentiment on Floraplex across formulator-focused discussions skews negative, particularly around CDT quality. One commenter on a Reddit thread in r/Terpenes noted they found the CDTs smelled “like meat,” at least at the time of purchase, which speaks to profile fidelity concerns that go well beyond what price alone can explain.
That kind of aromatic deviation from what a cannabis-derived terpene should express is a red flag for any formulator who needs predictable sensory outcomes across production runs.
A second commenter in the same thread, responding specifically about odor after having received a complimentary product bundle to review, confirmed that the team stopped reviewing Floraplex products altogether. The conclusion was direct: “You get what you pay for and these are some of the cheapest.”
That’s a particularly telling assessment coming from someone who didn’t pay for what they were evaluating and still found the quality below the threshold worth documenting. These are subjective assessments, but they pattern-match consistently with the objective documentation gaps that make independent quality verification difficult in the first place.
Why Terpene Belt Farms Should Be Your Next Terpene Supplier
Every gap that surfaces in a Floraplex evaluation points to something that properly documented CDT suppliers address as a baseline requirement. Full terpene panel data on every product, third-party accredited COAs, verified agricultural sourcing chains, and disclosed extraction methodology aren’t premium features.
They’re what professional procurement standards require when your finished product carries your brand’s name. Terpene Belt Farms was designed from the ground up around that standard: California-grown hemp, Fresh Never Frozen extraction, ISO/IEC 17025-accredited lab testing on every batch, and product-level documentation that covers every column in a qualified supplier audit.
The result is a supply chain where formulators know exactly what’s going into their product, at every stage, batch to batch. If your operation needs CDT inputs backed by full analytical documentation, verified cultivation origins, and a cGMP-certified processing facility, the sourcing gap between Floraplex and a serious CDT partner becomes straightforward to evaluate.
Frequently Asked Questions About Floraplex Terpenes
Is Floraplex Terpenes a Legitimate Operating Business?
Yes. Floraplex is a registered company operating as FLPX, LLC with a trademark registered in the United States, and it has been actively selling terpene products through BuyTerpenesOnline.com since 2018. Being a registered business is a separate question from whether the company’s documentation practices meet the standards required for B2B procurement in regulated product categories.
What Is the Difference Between Floraplex Botanical Blends and CDT Lines?
Botanical blends are formulated from terpene isolates sourced from non-cannabis plants. CDT lines use hemp-derived terpene material as a base, either alone (Pure), combined with botanical compounds (Fusion), or layered with added flavoring (Amped). The Pure CDT tier is the closest to authentic cannabis-derived profiles, though Floraplex does not publicly disclose the extraction methodology, cultivation origins, or harvest details for those products.
Does Floraplex Do Third-Party Lab Testing?
The company states on its website that terpene blends are third-party tested for heavy metals, pesticides, herbicides, and residual solvents. In practice, the COAs accessible on the documents page for many products record only physical characteristics and are produced in-house. Multiple product documentation pages list pesticide, heavy metal, and terpene spec sheet entries with no working links. Where third-party testing does exist, it is inconsistently accessible across the catalog.
What Happened Between Floraplex and New York State in 2019?
New York State issued a subpoena to Floraplex Terpenes as part of the 2019 EVALI investigation, targeting a diluent product called Uber Thick. State lab tests found the product to be nearly pure vitamin E acetate. The CDC linked vitamin E acetate directly to lung injury in vape users, finding it in lung fluid samples from EVALI patients across 16 states. Floraplex was one of three companies nationally to receive subpoenas during that investigation.
Sources for this Article
- New England Journal of Medicine: “Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI” – nejm.org/doi/full/10.1056/NEJMoa1916433
- The Boston Globe: “Amherst company under investigation in connection with vaping crisis” – bostonglobe.com/news/marijuana/2019/09/11/amherst-company-under-vaping-investigation/EIkZH0SIXjxSX0hyM79MaL/story.html
- Reddit (r/Terpenes): “Floraplex product review” – reddit.com/r/Terpenes/comments/1318fz7
